Address
1540 Broadway
New York, NY 10036
United States of America (the)
Phone
212 295 5800
Website
Sector
Healthcare
Industry
Software - Application
Employees
847.33
First IPO Date
February 05, 2020
| Name | Title | Pay | Year Born |
| Ramy Farid | Chief Executive Officer, President & Director | 1.32M | 1965 |
| Richard A. Friesner | Co-Founder, Scientific Advisory Chairman and Director | 486,800 | 1953 |
| Mannix Aklian | Executive VP, Chief Commercial Officer and Global Head of Software Sales & Marketing | 556,190 | 1975 |
| Kenneth Patrick Lorton | Executive Vice President, Chief Technology Officer & Chief Operating Officer of Software | 736,839 | 1984 |
| Robert Lorne Abel | Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling R&D | 736,839 | 1982 |
| Richie Jain | Executive Vice President, Chief Financial Officer & Treasurer | 747,954 | 1985 |
| Yvonne Tran | Corporate Secretary, Chief Legal & People Officer | 867,447 | 1971 |
| Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships | 944,225 | 1968 |
| Mike Beachy | Senior Vice President of Software Development | 0 | N/A |
| Matt Repasky | Senior Vice President of Life Sciences Products | 0 | N/A |
| Lingle Wang | Senior Vice President of Scientific Development | 0 | N/A |
| Mathew D. Halls | Senior Vice President of Materials Science | 0 | N/A |
| Shane Brauner | Executive Vice President & Chief Information Officer | 0 | 1977 |
| Nathalie Lacoste | Senior Vice President of Life Science Business | 0 | N/A |
| Therese Abrams | Principal Accounting Officer | 0 | 1984 |
| William Goddard | Co-Founder & Scientific Advisor | 0 | N/A |
| Duncan Hamish Wright | Senior Vice President of Translational Science & Therapeutics Business Development | 0 | N/A |
| Jaren Irene Madden | Chief Corporate Affairs Officer & Head of Investor Relations | 0 | N/A |
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.